These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 29655463)

  • 21. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V
    Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue proteomics: a new investigative tool for renal biopsy analysis.
    Sedor JR
    Kidney Int; 2009 May; 75(9):876-9. PubMed ID: 19367311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine as a source for clinical proteome analysis: from discovery to clinical application.
    Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
    Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics and autoimmune kidney disease.
    Rovin BH; Klein JB
    Clin Immunol; 2015 Nov; 161(1):23-30. PubMed ID: 25979820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary biomarkers for acute kidney injury in dogs.
    De Loor J; Daminet S; Smets P; Maddens B; Meyer E
    J Vet Intern Med; 2013; 27(5):998-1010. PubMed ID: 23952327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Biomarkers for Renal Diseases? None for the Moment (but One).
    Gentile G; Remuzzi G
    J Biomol Screen; 2016 Aug; 21(7):655-70. PubMed ID: 26950928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic urinary biomarker approach in renal disease: from discovery to implementation.
    Schanstra JP; Mischak H
    Pediatr Nephrol; 2015 May; 30(5):713-25. PubMed ID: 24633400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?
    Bramham K; Mistry HD; Poston L; Chappell LC; Thompson AJ
    QJM; 2009 Aug; 102(8):523-38. PubMed ID: 19553250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
    Dubin RF; Rhee EP
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?
    Kessel C; McArdle A; Verweyen E; Weinhage T; Wittkowski H; Pennington SR; Foell D
    Curr Rheumatol Rep; 2018 Jul; 20(9):53. PubMed ID: 30008153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease.
    Albalat A; Franke J; Gonzalez J; Mischak H; Zürbig P
    Methods Mol Biol; 2013; 919():203-13. PubMed ID: 22976103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review.
    Lădaru A; Bălănescu P; Stan M; Codreanu I; Anca IA
    Biomarkers; 2016; 21(2):102-14. PubMed ID: 26632636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.
    Magalhães P; Mischak H; Zürbig P
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):494-501. PubMed ID: 27584928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
    Tesch GH
    Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.
    Zürbig P; Dihazi H; Metzger J; Thongboonkerd V; Vlahou A
    Proteomics Clin Appl; 2011 Jun; 5(5-6):256-68. PubMed ID: 21591267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics biomarkers for solid tumors: Current status and future prospects.
    Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
    Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of urinary proteomics in renal disease research using animal models.
    Lv Y; Cai G; Chen X
    Adv Exp Med Biol; 2015; 845():145-50. PubMed ID: 25355577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.